NCT06979557 is a clinical trial of Odyssey IOL in Refractive Lens Exchange, sponsored by Mann Eye Institute.

Who is sponsoring NCT06979557?

NCT06979557 is sponsored by Mann Eye Institute.

What drugs are being tested in NCT06979557?

Interventions in NCT06979557: Odyssey IOL.

What condition does NCT06979557 study?

NCT06979557 studies Refractive Lens Exchange.

Is NCT06979557 still recruiting?

NCT06979557 is currently completed. Last updated 27 February 2026.

Last reviewed 2026-02-27 · How we verify

NCT06979557

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

RLE Outcomes With Bilateral Implantation of Odyssey IOLs

Completed Last updated 27 February 2026

What this trial tests

trial testing Odyssey IOL in Refractive Lens Exchange in 40 participants. Completed in 1 January 2026.

Timeline

21 July 2025

Primary endpoint
1 January 2026

1 January 2026

Quick facts

Lead sponsor	Mann Eye Institute
Status	Completed
Study type	OBSERVATIONAL
Enrollment	40
Start date	21 July 2025
Primary completion	1 January 2026
Estimated completion	1 January 2026
Sites	1 location across United States

Drugs / interventions tested

Odyssey IOL

Conditions studied

Refractive Lens Exchange — all drugs for Refractive Lens Exchange →

Sponsor

Mann Eye Institute

Who can join

40 and older, any sex, with Refractive Lens Exchange. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is a single center, ambispective study of visual outcomes after successful bilateral implantation of the Odyssey IOL. Subjects will be assessed at least 2 months postoperatively at a single visit. Clinical evaluations will include administration of the AIOLIS questionnaire, as well as measurement of visual acuities at distance, intermediate, and near, monocular (right eye) and binocular defocus curve, and refractive outcomes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Mann Eye Institute trials

Trials by the same sponsor.

NCT07281391 — IOP Reduction in Pigmentary Glaucoma Using DSLT · recruiting
NCT07084844 — Patient Reported Outcomes With WaveLight Plus LASIK · recruiting
NCT06550375 — Clinical Outcomes With Bilateral Implantation of Odyssey IOLs · completed
NCT05886452 — Success of Dailies Total1 for Astigmatism Contact Lenses in Patients That Have Previously Failed With Toric Contact Lens · completed
NCT05848817 — Patient Reported Satisfaction With Contoura LASIK Utilizing the Phorcides Analytic Software · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06979557 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Mann Eye Institute
Last refreshed: 27 February 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06979557.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing